| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | Chief Business Development Off
1 company
Gano Kyle is a Chief Executive Officer at NEUROCRINE BIOSCIENCES INC. Recent SEC Form 4 filings include 0 buys and 24 sells.
Estimated insider holdings value: $21.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 8, 2023 | NBIX Neurocrine Biosciences Inc | Chief Business Development Off | Sell | 17,004 | $102.79 | $1,747,919.93 | -3.4% | -6.9% | +28.6% | |
| Jan 31, 2023 | NBIX Neurocrine Biosciences Inc | Chief Business Development Off | Sell | 1,541 | $109.98 | $169,486.42 | -1.3% | -6.2% | +26.0% | |
| Feb 8, 2022 | NBIX Neurocrine Biosciences Inc | Chief Business Development Off | Sell | 6,880 | $80.61 | $554,627.74 | -1.3% | -5.2% | +30.7% | |
| Jan 5, 2022 | NBIX Neurocrine Biosciences Inc | Chief Business Development Off | Sale+OE | 28,266 | $85.50 | $2,416,751.48 | -21.2% | +16.6% | +47.7% | |
| Feb 8, 2021 | NBIX Neurocrine Biosciences Inc | Chief Business Development Off | Sell | 6,370 | $115.65 | $736,702.16 | -1.2% | - | - | |
| Nov 12, 2020 | NBIX Neurocrine Biosciences Inc | Chief Business Development Off | Sell | 2,257 | $90.73 | $204,770.39 | -2.3% | - | - | |
| Aug 5, 2020 | NBIX Neurocrine Biosciences Inc | Chief Business Development Off | Sell | 2,257 | $118.87 | $268,285.53 | -2.3% | - | - | |
| Apr 24, 2020 | NBIX Neurocrine Biosciences Inc | Chief Business Development Off | Sell | 1,934 | $99.47 | $192,376.72 | -2.0% | - | - | |
| Feb 7, 2020 | NBIX Neurocrine Biosciences Inc | Chief Business Development Off | Sell | 1,623 | $103.33 | $167,710.27 | -1.7% | - | - | |
| Feb 6, 2020 | NBIX Neurocrine Biosciences Inc | Chief Business Development Off | Sell | 4,690 | $102.70 | $481,674.98 | -1.3% | - | - |